Position in SVTR
Snapshot 2026-10-20- Startup SignalsTop 50%↓19
- Life SciencesTop 50%↓2
- AgentsTop 50%↓6
- Healthcare ServicesRankedof 84↓1
- AudioTop 50%↓1
About
Confido Health, founded in 2022 in New York, USA, provides AI voice agents to handle and document patient phone calls.
Full tier & rationale — an SVTR Intelligence benefit
Timeline
- 2026-10-15FundingA轮$13M
- 2025-10FundingA轮$10M
- 2024-12Funding种子轮$3M
Public events aggregated from this page; rating changes are member-only.
Capital graph
Founders / core team
Investors
Funding history
- 2026-10-15Series A$13M
Investors · Z47、Together Fund、Blume Ventures
- 2025-10Series A$10M
Investors · Blume Ventures、DeVC、MedMountain Ventures、Schema Ventures、Vicus Ventures、Together Fund
Source · SVTR Weekly #125 - 2024-12Seed$3M
Investors · Rebellion VC、Operators Studio、DeVC、MedMountain Ventures、Together Fund
Source · SVTR Weekly #084
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Confido Health
Confido Health, founded in 2022 in New York, USA, provides AI voice agents to handle and document patient phone calls.
Series A · $26M · 2026-10
$26M
United States
BusinessLatest roundTotal raisedDate- Assort Health
Assort Health, founded in 2023 in San Francisco, provides a voice AI agent platform for healthcare organizations that automates appointment scheduling, triage, referrals, documentation, and payment processing.
Series C · $222M · 2026-06 · Valuation $1.2B
$222MValuation $1.2B - Citizen Health
Citizen Health, founded in 2023 in San Mateo, USA, builds an AI health advocacy assistant that helps patients with rare and complex diseases interpret medical records, document symptoms, connect with peers, and advance their care journey.
Series A · $46M · 2025-08
$46M - Freed
Freed, founded in 2022 in San Francisco, offers an AI-powered assistant that helps clinicians document patient visits by transcribing conversations and generating SOAP notes.
Series A · $30M · 2025-03
$30M
Europe
BusinessLatest roundTotal raisedDate- Vocca
Vocca, founded in 2024 in Paris with an office in New York, builds specialty-specific AI voice agents for medical practices that pair natural-language models with clinical scheduling rules to answer patient calls and book, reschedule or cancel appointments directly in existing practice-management and EHR systems, plus reminders, exam prep and patient reactivation. It serves 1,500+ practices across 20+ specialties in the US and Europe, handling over a million calls a month with about 70% resolved without staff.
Series A · $25M · 2026-10
$25M - Iomed
Iomed, founded in 2016 in Barcelona, Spain, uses natural language processing to extract data from medical records, clinical trials, and patient surveys.
Series A · $11M · 2023-09
$11M - Voize
Voize, founded in 2020 in Potsdam, Germany, provides an AI-powered mobile app that enables care workers to document patient information via voice input, automatically generating structured reports.
Series A · $59M · 2025-11
$59M
Other / unspecified
BusinessLatest roundTotal raisedDate- Kraionyx AI
Founded in 2025 in Hyderabad, India, Kraionyx AI builds high-assurance agentic AI systems for healthcare as "the intelligence layer" for clinicians: KareOS (clinical decision-support workspace with specialist medical agents), Svaani (ambient voice intelligence turning doctor-patient conversations into clinical documentation) and Doclave (a professional network for doctors to discuss cases).
— - Heidi Health
Heidi Health (formerly Oscer), founded in 2019 in Melbourne, Australia, reduces administrative burden on physicians by using AI to convert consultation recordings into medical histories, referral letters, billing forms, and other clinical documents.
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M - Guardoc Health
Guardoc Health, founded in 2021 in Tel Aviv, provides AI software that identifies errors, discrepancies, and gaps in real-time clinical documentation within electronic health records.
Seed · $3M · 2024-08
$3M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 25 at a nearby stage · 35 in NYC Metro
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 33 at a nearby stage · 31 in NYC Metro
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 12 at a nearby stage · 22 in NYC Metro
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 10 at a nearby stage · 20 in NYC Metro
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 15 in NYC Metro
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 11 at a nearby stage · 14 in NYC Metro
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.